Bluejay Diagnostics, Inc. (BJDX)
USD 3.54
(8.92%)
USD 3.54
(8.92%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.86 Million USD | -63.99% |
| 2022 | 13.52 Million USD | -35.67% |
| 2021 | 21.01 Million USD | 1285.25% |
| 2020 | 1.51 Million USD | 65.55% |
| 2019 | 916.51 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 5.07 Million USD | 4.24% |
| 2024 Q2 | 10.85 Million USD | 113.97% |
| 2023 Q4 | 4.86 Million USD | -40.96% |
| 2023 FY | 4.86 Million USD | -63.99% |
| 2023 Q3 | 8.24 Million USD | -2.73% |
| 2023 Q2 | 8.47 Million USD | -22.13% |
| 2023 Q1 | 10.88 Million USD | -19.47% |
| 2022 Q3 | 15.7 Million USD | -13.07% |
| 2022 Q2 | 18.06 Million USD | -10.03% |
| 2022 Q1 | 20.08 Million USD | -4.46% |
| 2022 FY | 13.52 Million USD | -35.67% |
| 2022 Q4 | 13.52 Million USD | -13.91% |
| 2021 Q1 | - USD | -100.0% |
| 2021 Q2 | 3.12 Million USD | 0.0% |
| 2021 Q4 | 21.01 Million USD | 480.2% |
| 2021 Q3 | 3.62 Million USD | 15.91% |
| 2021 FY | 21.01 Million USD | 1285.25% |
| 2020 Q4 | 1.51 Million USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | 1.51 Million USD | 65.55% |
| 2019 FY | 916.51 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | 84.478% |
| BrainsWay Ltd. | 62.97 Million USD | 92.269% |
| Cerus Corporation | 197.74 Million USD | 97.538% |
| Envoy Medical, Inc. | 7.64 Million USD | 36.276% |
| electroCore, Inc. | 16.38 Million USD | 70.29% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | 36.707% |
| IceCure Medical Ltd | 16.41 Million USD | 70.332% |
| Inogen, Inc. | 326.19 Million USD | 98.507% |
| OrthoPediatrics Corp. | 449.58 Million USD | 98.917% |
| Lucid Diagnostics Inc. | 27.27 Million USD | 82.147% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | 70.634% |
| MaxCyte, Inc. | 268.27 Million USD | 98.185% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | 39.875% |
| Nexalin Technology, Inc. | 3.63 Million USD | -34.049% |
| Orthofix Medical Inc. | 925.31 Million USD | 99.474% |
| PAVmed Inc | 33.11 Million USD | 85.3% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 96.606% |
| RxSight, Inc. | 182.55 Million USD | 97.333% |
| Sight Sciences, Inc. | 166.65 Million USD | 97.079% |
| SI-BONE, Inc. | 230.42 Million USD | 97.887% |
| TELA Bio, Inc. | 78.04 Million USD | 93.762% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 98.067% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | 54.627% |
| Acutus Medical, Inc. | 53.96 Million USD | 90.978% |
| Talis Biomedical Corporation | 98.34 Million USD | 95.049% |
| Spectral AI, Inc. | 10.69 Million USD | 54.466% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 97.773% |
| CVRx, Inc. | 115.22 Million USD | 95.775% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 91.701% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -56.28% |
| Bioventus Inc. | 810.91 Million USD | 99.4% |
| Venus Concept Inc. | 93.65 Million USD | 94.802% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | 81.075% |
| LivaNova PLC | 2.42 Billion USD | 99.8% |
| 908 Devices Inc. | 202.98 Million USD | 97.601% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 99.395% |
| Nemaura Medical Inc. | 14.56 Million USD | 66.57% |
| NeuroPace, Inc. | 107.65 Million USD | 95.477% |
| LENSAR, Inc. | 69.58 Million USD | 93.003% |
| Apyx Medical Corporation | 79.24 Million USD | 93.856% |
| Cutera, Inc. | 346.29 Million USD | 98.594% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | 88.413% |
| BioSig Technologies, Inc. | 1.79 Million USD | -170.775% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 98.201% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 88.588% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.871% |
| Axonics, Inc. | 719.92 Million USD | 99.324% |
| Outset Medical, Inc. | 313.8 Million USD | 98.449% |
| IRIDEX Corporation | 34.43 Million USD | 85.862% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 98.797% |
| IRadimed Corporation | 92.15 Million USD | 94.717% |
| Tivic Health Systems, Inc. | 5.25 Million USD | 7.337% |
| INVO Bioscience, Inc. | 20.88 Million USD | 76.692% |
| Telesis Bio, Inc. | 70.41 Million USD | 93.086% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 96.841% |
| Varex Imaging Corporation | 1.24 Billion USD | 99.61% |
| Quipt Home Medical Corp. | 247.4 Million USD | 98.032% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | 47.706% |
| Pulmonx Corporation | 178.95 Million USD | 97.279% |
| Dynatronics Corporation | 25.94 Million USD | 81.232% |
| Modular Medical, Inc. | 13.8 Million USD | 64.739% |
| ReShape Lifesciences Inc. | 10.72 Million USD | 54.614% |
| Semler Scientific, Inc. | 78.06 Million USD | 93.763% |
| InMode Ltd. | 863.28 Million USD | 99.436% |
| Bruker Corporation | 4.24 Billion USD | 99.885% |
| Cytosorbents Corporation | 53.26 Million USD | 90.859% |
| DexCom, Inc. | 6.26 Billion USD | 99.922% |
| Align Technology, Inc. | 6.08 Billion USD | 99.92% |
| Viveve Medical, Inc. | 25.91 Million USD | 81.212% |
| ZimVie Inc. | 1.2 Billion USD | 99.596% |
| Movano Inc. | 9.42 Million USD | 48.323% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 99.022% |
| Nexalin Technology, Inc. | 3.63 Million USD | -34.049% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 91.701% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 99.489% |
| Profound Medical Corp. | 43.68 Million USD | 88.856% |
| Insulet Corporation | 2.58 Billion USD | 99.812% |
| enVVeno Medical Corporation | 48.63 Million USD | 89.99% |
| Surmodics, Inc. | 185.73 Million USD | 97.379% |
| iCAD, Inc. | 41.41 Million USD | 88.245% |
| Nuwellis, Inc. | 9.77 Million USD | 50.169% |
| Biotricity, Inc. | 5.94 Million USD | 18.074% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 98.876% |
| Aethlon Medical, Inc. | 8.24 Million USD | 40.959% |
| InspireMD, Inc. | 47.64 Million USD | 89.781% |
| PAVmed Inc. | 33.11 Million USD | 85.3% |
| BIOLASE, Inc. | 35.1 Million USD | 86.13% |
| Beyond Air, Inc. | 56.96 Million USD | 91.453% |
| FONAR Corporation | 214.24 Million USD | 97.728% |
| AxoGen, Inc. | 196.82 Million USD | 97.526% |
| Vivani Medical, Inc. | 45.79 Million USD | 89.369% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 98.27% |
| Inari Medical, Inc. | 674.23 Million USD | 99.278% |
| UFP Technologies, Inc. | 404.13 Million USD | 98.795% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | 79.193% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | 48.769% |
| Tenon Medical, Inc. | 6.34 Million USD | 23.27% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | 48.246% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 95.303% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.895% |
| Sintx Technologies, Inc. | 15.36 Million USD | 68.314% |
| NanoVibronix, Inc. | 6.67 Million USD | 27.052% |
| Quanterix Corporation | 425.01 Million USD | 98.854% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | 47.706% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 90.938% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 99.721% |
| TransMedics Group, Inc. | 706.04 Million USD | 99.31% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 92.296% |
| NeuroMetrix, Inc. | 21.42 Million USD | 77.276% |
| Hyperfine, Inc. | 94.19 Million USD | 94.832% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 98.188% |
| Biomerica, Inc. | 9.25 Million USD | 47.39% |
| Bone Biologics Corporation | 3.73 Million USD | -30.253% |
| AVITA Medical, Inc. | 144.33 Million USD | 96.627% |
| Silk Road Medical, Inc | 265.3 Million USD | 98.165% |